Ardian said Monday that it has entered exclusive negotiations to sell its majority stake in Novacap to Eurazeo and Mérieux Développement. Financial terms weren’t announced. Ardian will remain a minority shareholder. Novacap, of Lyon, France, is a diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products.
Paris, March 21st 2016 – Ardian, the independent private investment company, today announces that it has entered into exclusive negotiations with Eurazeo and Mérieux Développement to sell its majority stake in Novacap, the global diversified chemicals group. Ardian would remain a minority shareholder therefore reaffirming its confidence in the management team.
Based in Lyon (France), Novacap is a global diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products. It enjoys leading positions in its target growth end-markets of pharmaceuticals & healthcare, food & feed, cosmetics & fragrances, home care and environment.
Since acquiring its original stake in Novacap in 2011, Ardian has supported the company in its external and organic growth, reinforcing its position as a leader in specialty chemicals while successfully implementing its international expansion strategy.
ABOUT NOVACAP GROUP
Novacap is a global diversified chemicals group that produces and distributes essential chemicals used in everyday products, with leading positions in its target end-markets of pharmaceutical & healthcare, cosmetics & fragrances, food & feed, home care and environment. The group is an industry leader across a wide range of products including aspirin, paracetamol, other APIs, ketamine, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents, hydrochloric acid and ferric chloride. With an increasing international footprint fueled by organic growth, acquisitions and solid partnerships, the group is experiencing sustainable and profitable growth, demonstrating its entrepreneurial spirit and audacious strategy. Moreover, as a key player in the chemical industry and supplier than 750 customers, we consider the chemistry of tomorrow will necessarily be achieved through responsible supplies, responsible production and responsible sales, so as to ensure our business sustainability. In order to support this vision, we focus our energies on 3 mains commitments: Economic performance, Social and Corporate Responsibility and Environmental Protection. With 14 worldwide facilities, c.1,600 people and a global commercial network, the group is organized into three business divisions: Mineral Specialties, Pharmaceutical & Cosmetics and Performance Chemicals. Novacap is headquartered in Lyon (France). For more information: Communications Direction + 33 4 26 99 18 00 – www.novacap.eu
Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fuelling growth in economies across the world. Ardian’s investment process embodies three values: excellence, loyalty and entrepreneurship. Ardian maintains a truly global network, with more than 410 employees working through twelve offices in Paris, London, Frankfurt, Milan, Madrid, Zurich, New York, San Francisco, Beijing, Singapore, Jersey and Luxembourg. The company offers its 470 investors a diversified choice of funds covering the full range of asset classes through Ardian Funds of Funds (comprising primary, early secondary and secondary activities), Ardian Private Debt, Ardian Direct Funds (comprising Ardian Mid Cap Buyout, Ardian Expansion, Ardian Growth and Ardian Co-Investment), Ardian Infrastructure, Ardian Real Estate and customized mandate investment solutions with Ardian Mandates. www.ardian.com
With a diversified portfolio of 5 billion euros in assets, Eurazeo is one of the leading listed investment companies in Europe. Its purpose and mission is to identify, accelerate and enhance the transformation potential of the companies in which it invests. The Company covers most private equity segments through its four business divisions – Eurazeo Capital, Eurazeo Croissance, Eurazeo PME and Eurazeo Patrimoine. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo is notably either a majority or key shareholder in AccorHotels, ANF Immobilier, Asmodee, Desigual, Elis, Europcar, Fintrax, Foncia, InVivo NSA, Moncler, and smaller companies, including the investments of Eurazeo PME and Eurazeo Croissance.
Eurazeo is listed on Euronext Paris.
ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA
ABOUT MÉRIEUX DÉVELOPPEMENT
Mérieux Développement is an affiliate of Institut Mérieux, which employs around 15,000 employees worldwide with consolidated revenues exceeding 2.4 billion Euros in 2015. Mérieux Développement is an evergreen fund specialized in the healthcare sector, conducting venture capital and private equity transactions worldwide. Mérieux Développement brings its expertise and global network to enable outstanding entrepreneurs to disrupt and create new markets:
· Capacity to help qualify acquisition targets in the USA, in Europe and in emerging countries;
· Potential support and guidance on pharma business expansion;
· Identifying talents and also innovative technology platforms or products which could be relevant to Novacap’s business units